Page last updated: 2024-10-29

isoflurane and Charcot-Marie-Tooth Disease

isoflurane has been researched along with Charcot-Marie-Tooth Disease in 2 studies

Isoflurane: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.

Charcot-Marie-Tooth Disease: A hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bui, AH1
Marco, AP1
Greenberg, RS1
Parker, SD1

Reviews

1 review available for isoflurane and Charcot-Marie-Tooth Disease

ArticleYear
Anesthetic management for the child with Charcot-Marie-Tooth disease.
    Anesthesia and analgesia, 1992, Volume: 74, Issue:2

    Topics: Anesthesia, Inhalation; Charcot-Marie-Tooth Disease; Child; Fractures, Bone; Humans; Isoflurane; Mal

1992

Other Studies

1 other study available for isoflurane and Charcot-Marie-Tooth Disease

ArticleYear
Peripheral nerve blockade in a patient with Charcot-Marie-Tooth disease.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2008, Volume: 55, Issue:10

    Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Anesthetics, Local; Bupivacaine; Charcot-Marie-To

2008